Ten years of survival among early-stage breast cancer patients: a hospital-based study
Keywords:Survival, Outcome, Mortality, Early-stage breast cancer, Oncology
Background: The incidence rate of breast cancer is gradually increasing all over the world. In Bangladesh, we have very little research-based information regarding the survival of patients with early-stage breast cancer. The aim of this study was to determine the survival outcome of early-stage (Stages I- IIIA) breast cancer among female patients in respect to their age group, stage of the disease, tumor grade, nodal status, and hormone receptor status
Methods: This was a prospective observational study focused on the survival outcome conducted in the department of clinical oncology, Bangabandhu Sheikh Mujib medical university (BSMMU), Dhaka, Bangladesh during the period from December 2011 to December 2021. One hundred and five (105) female patients with early-stage (Stages I-IIIA) breast cancer were selected following the inclusion and exclusion criteria as the study subjects. Properly informed written consent was taken from all the participants before starting data collection. All data were processed, analyzed, and disseminated by MS office and SPSS programs as per need.
Results: The survival rate was found 79% (n=83). We observed stage-wise 10-year overall survival among the participants where 51.60%, 36.10%, and 12.30% survived from tumor stage I, II, and III respectively. We also observed that 29%, 60% and 11% of patients had survived from tumor grade I, II, and III respectively (Out of 83 survival cases). On the other hand, among the 83 10-year survival patients, 53.8% were of negative nodal status whereas 34.20% were of positive nodal status patients. Among the survived 83 patients, 86% were from >40 years’ age group whereas the rest 14% were from <40 years of age group.
Conclusions: Early detection and treatment of breast cancer provide a definitive survival benefit. The results of the study showed that comprehensive screening and early detection of breast cancer is required to improve the survival outcome.
Doval DC, Radhakrishna S, Tripathi R, Kashinath RI, Talwar V, Batra U et al. A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery. Scientific Rep. 2020;10(1):5886.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide. IARC Cancer Base 2012;10. Available at: http://globocan.iarc.fr. Accessed on 2022 September, 09.
Hery C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol. 2008;19(6):1187-94.
Autier P, Hery C, Haukka J, Boniol M, Byrnes G. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. JCO. 2009;27(35):5919-23.
Macià F, Porta M, Murta-Nascimento C, Servitja S, Guxens M, Burón A et al. Factors affecting 5- and 10-year survival of women with breast cancer: an analysis based on a public general hospital in Barcelona. Cancer Epidemiol. 2012;36(6):554-9.
Peto R, Early Breast Cancer Trialists’ Collaborative Group. The worldwide overview: new results for systemic adjuvant therapies. InSan Antonio breast cancer symposium. 2007;13-6.
Ganesh B, Talole SD, Dikshit R, Badwe RA, Dinshaw KA. Estimation of survival rates of breast cancer pa- tients - a hospital-based study from Mumbai. Asian Pac J Cancer Prev. 2008;9(1):53-7.
Ortiz AP, Frías O, Pérez J, Cabanillas F, Martínez L, Sán- chez C et al. Breast cáncer molecular subtypes and survival in a hospital-based sample in Puerto Rico. Can- cer Med. 2013;2(3):343-50.
Mendonça GAS, Silva AM, Caula WM. Tumor characteristics and five-year survival in breast cancer patients at the National Cancer Institute, Rio de Janeiro, Brazil. Cad Saude Publica. 2004;20(5):1232-9.
Moraes AB, Zanini RR, Turchiello MS, Riboldi J, Me- deiros RL. Survival study of breast cancer patients treated at the hospital of the Federal University in San- ta Maria, Rio Grande do Sul, Brazil. Cad Saude Publica. 2006;22(10):2219-28.
Schneider IJC, D’Orsi E. Five-year survival and prog- nostic factors in women with breast cancer in San- ta Catarina State, Brazil. Cad Saude Publica. 2009;25(6):1285-96.
Hosmer DW, Lemeshow S, May S. Applied survival analysis: regression modelling of time-to-event data. 2nd ed. Hoboken: John Wiley and Sons. 2008.
Carneseca EC, Mauad EC, Araujo MAA, Dalbó RM, Longatto Filho A, Vazquez VL. The Hospital de Cancer de Barretos Registry: an analysis of cancer survival at a single institution in Brazil over a 10-year period. BMC Res Notes. 2013;6:141.
Höfelmann DA, Anjos JC, Ayala AL. Survival for ten years and prognostic factors for women with breast cancer in Joinville in the State of Santa Catarina, Brazil. Cien Saude Colet. 2014;19(6):1813-24.
Hayes DF. Clinical practice. Follow-up of patients with early breast cancer. New Engl J Med. 2007;356(24):2505-13.
Sundquist M, Thorstenson S, Brudin L, Wingren S, Nordenskjöld B. Incidence and prognosis in early onset breast cancer. Breast 2002; 11(1):30-35.
Behm EC, Beckmann KR, Dahlstrom JE, Zhang Y, Cho C, Stuart-Harris R et al. Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the breast cancer treatment quality assurance project. Breast. 2013;22(5):839-44.
Ishida T, Takeda M, Suzuki A, Amari M, Moriya T, Ohuchi N. Significance of irradiation in breast-con- serving treatment: comparison of local recurrence rates in irradiated and nonirradiated groups. Int J Clin Oncol. 2008;13(1):12-7.